U.S. specialists and familiarity with biosimilars 2021

Published by
Matej Mikulic,
Apr 23, 2024
According to a survey conducted in 2021, 94 percent of oncologists indicated being very or somewhat familiar with biosimilars. The percentage of physicians who are "very familiar" with biosimilars was highest among diabetes specialists.

Familiarity with biosimilars among specialized physicians in the U.S. as of 2021

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

2022

Region

United States

Survey time period

as of 2021

Number of respondents

581 respondents

Supplementary notes

The survey included: oncology prescribers (n=323); rheumatology prescribers (n=102); ophthalmology prescribers (n=102); diabetes prescribers (n=54).

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

9

Selected statistics

6

Other regions

10

Related statistics

10

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Generics and biosimilars in ItalyTop pharmaceutical drugsHealth and food supplements market in ItalyNon-prescription drugs in ItalyPharmaceutical market in Italy
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu